Detalhe da pesquisa
1.
Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.
Cancer Sci
; 111(8): 2760-2769, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495455
2.
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
Cancer Immunol Immunother
; 69(5): 847-857, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025848
3.
Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase.
Cancer Sci
; 109(3): 611-617, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388341
4.
Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
Cancer Sci
; 109(9): 2660-2669, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938870
5.
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies.
Cancer Sci
; 108(9): 1732-1738, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622427
6.
A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer.
Cancer Sci
; 108(5): 838-845, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188670
7.
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
Cancer Sci
; 108(12): 2430-2437, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940789
8.
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele.
Cancer Sci
; 108(4): 598-603, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178396
9.
Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients.
Cancer Sci
; 107(5): 590-600, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26920496
10.
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
Cancer Immunol Immunother
; 65(10): 1223-31, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27549314
11.
[Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment].
Gan To Kagaku Ryoho
; 43(10): 1249-1251, 2016 Oct.
Artigo
em Japonês
| MEDLINE | ID: mdl-27760950
12.
Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2(+) cancer patients as cancer vaccine.
Cancer Sci
; 106(11): 1493-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26331453
13.
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele.
Cancer Sci
; 106(10): 1257-63, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26212219
14.
Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.
Cancer Sci
; 104(10): 1285-94, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23829867
15.
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.
Cancer
; 118(12): 3208-21, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22071976
16.
Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides.
Virol J
; 9: 199, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22979950
17.
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.
Mol Clin Oncol
; 14(2): 39, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437477
18.
Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.
Exp Ther Med
; 22(2): 905, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249152
19.
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Cancer Immunol Immunother
; 59(7): 1001-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20146063
20.
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
Int J Oncol
; 56(6): 1479-1489, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236612